World's Best Scientists 2026 revealed!
Isabelle Cremer

Isabelle Cremer

D-Index & Metrics

Immunology

D-Index
57
Citations
12870
World Ranking
3611
National Ranking
166

Isabelle Cremer publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Isabelle Cremer sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 105 publications — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Isabelle Cremer D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Isabelle Cremer sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 57 D-Index — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Isabelle Cremer is affiliated with Sorbonne University in France and has contributed extensively to the fields of Medicine and Immunology and Microbiology. Their research primarily focuses on Oncology, Immunology, Molecular Biology, Epidemiology, and Pulmonary and Respiratory Medicine.

The main topics covered in their research include:

  • Cancer Immunotherapy and Biomarkers
  • Immune Cell Function and Interaction
  • Immunotherapy and Immune Responses
  • Immune cells in cancer
  • Peptidase Inhibition and Analysis
  • RNA modifications and cancer
  • Autophagy in Disease and Therapy

Among recent publications showcasing Isabelle Cremer's contributions are:

  • "Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions," 2020, Journal for ImmunoTherapy of Cancer
  • "Intracellular Factor H Drives Tumor Progression Independently of the Complement Cascade," 2021, Cancer Immunology Research
  • "Complement C1s and C4d as Prognostic Biomarkers in Renal Cancer: Emergence of Noncanonical Functions of C1s," 2021, Cancer Immunology Research
  • "NK cells in the tumor microenvironment: Prognostic and theranostic impact. Recent advances and trends," 2020, Seminars in Immunology
  • "SMARCA4-deficient lung carcinoma is an aggressive tumor highly infiltrated by FOXP3+ cells and neutrophils," 2022, Lung Cancer

The frequent coauthors who have collaborated with Isabelle Cremer include:

  • Marco Alifano (18 joint publications)
  • Diane Damotte (17 joint publications)
  • Marie Wislez (13 joint publications)
  • Jules Russick (8 joint publications)
  • Audrey Mansuet-Lupo (8 joint publications)

Isabelle Cremer's research appears regularly in the following publication venues:

  • Journal for ImmunoTherapy of Cancer (3 publications)
  • Cancer Immunology Research (3 publications)
  • Lung Cancer (2 publications)
  • Frontiers in Immunology (2 publications)
  • European Journal of Cancer (2 publications)

This profile illustrates research centered on cancer immunotherapy, immune cell function, and interaction within tumor microenvironments, reflecting a multidisciplinary approach bridging oncology and immunology with molecular and pulmonary insights.

Best Publications

  • Consensus guidelines for the detection of immunogenic cell death

    Oliver Kepp;Laura Senovilla;Ilio Vitale;Erika Vacchelli

  • Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer

    Claire Germain;Sacha Gnjatic;Fella Tamzalit;Samantha Knockaert

  • Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells.

    Jérémy Goc;Claire Germain;Thi Kim Duy Vo-Bourgais;Audrey Lupo

  • Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma

    Sophia Platonova;Julien Cherfils-Vicini;Diane Damotte;Lucile Crozet

  • Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity

    Corneliu Henegar;Joan Tordjman;Vincent Achard;Danièle Lacasa

  • Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin

    Romain Remark;Marco Alifano;Isabelle Cremer;Audrey Lupo

  • Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors

    Nicolas F. Delahaye;Sylvie Rusakiewicz;Sylvie Rusakiewicz;Isabelle Martins;Cédric Ménard;Cédric Ménard

  • Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer

    Luc de Chaisemartin;Jeremy Goc;Diane Damotte;Pierre Validire

  • TP53, STK11, and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma

    Jerome Biton;Jerome Biton;Audrey Mansuet-Lupo;Nicolas Pécuchet;Marco Alifano

  • Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors

    Sylvie Rusakiewicz;Michaela Semeraro;Matthieu Sarabi;Mélanie Desbois

  • Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy.

    Jonathan Pol;Erika Vacchelli;Fernando Aranda;Francesca Castoldi

  • Immune Infiltration in Human Cancer: Prognostic Significance and Disease Control

    Wolf H. Fridman;Jérome Galon;Jérome Galon;Marie-Caroline Dieu-Nosjean;Marie-Caroline Dieu-Nosjean;Isabelle Cremer;Isabelle Cremer

  • CD14dimCD16+ and CD14+CD16+ Monocytes in Obesity and During Weight Loss Relationships With Fat Mass and Subclinical Atherosclerosis

    Christine Poitou;Elise Dalmas;Mariana Renovato;Vanessa Benhamo

  • Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance

    Julien Cherfils-Vicini;Sophia Platonova;Mélanie Gillard;Ludivine Laurans

  • T cell-derived IL-22 amplifies IL-1β-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes.

    Elise Dalmas;Nicolas Venteclef;Charles Caer;Christine Poitou

  • Trial watch: Chemotherapy with immunogenic cell death inducers.

    Erika Vacchelli;Laura Senovilla;Alexander Eggermont;Wolf Hervé Fridman

  • Trial watch: Oncolytic viruses for cancer therapy

    Erika Vacchelli;Alexander Eggermont;Catherine Sautès-Fridman;Jérôme Galon

  • Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword.

    Marion Dajon;Kristina Iribarren;Kristina Iribarren;Kristina Iribarren;Isabelle Cremer;Isabelle Cremer;Isabelle Cremer

  • Trial watch: Dendritic cell-based interventions for cancer therapy.

    Erika Vacchelli;Ilio Vitale;Alexander Eggermont;Wolf Hervé Fridman

  • Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancer.

    Marco Alifano;Audrey Mansuet-Lupo;Filippo Lococo;Nicolas Roche

  • Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis.

    Jitka Fucikova;Etienne Becht;Etienne Becht;Etienne Becht;Kristina Iribarren;Kristina Iribarren;Kristina Iribarren;Jeremy Goc;Jeremy Goc;Jeremy Goc

Frequent Co-Authors

Catherine Sautès-Fridman
Catherine Sautès-Fridman Université Paris Cité
Guido Kroemer
Guido Kroemer Université Paris Cité
Lorenzo Galluzzi
Lorenzo Galluzzi Cornell University
Laurence Zitvogel
Laurence Zitvogel University of Paris-Saclay
Alexander M.M. Eggermont
Alexander M.M. Eggermont Institut Gustave Roussy
Jitka Fucikova
Jitka Fucikova Charles University
Radek Spisek
Radek Spisek Sotio (Czechia)
Wolf H. Fridman
Wolf H. Fridman Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your qualifications with specialized nursing degrees can open diverse career opportunities. Mental health and psychiatric care are growing fields closely linked to Immunology, particularly in understanding neuroimmune responses. Exploring online pmhnp programs with clinical placement ensures hands-on experience, which is crucial for success in these advanced practice roles.

Cost is often a barrier for many students. Fortunately, there are several cheapest online pmhnp programs that provide high-quality education without overwhelming debt. These programs make advanced degrees more accessible and can be pursued alongside professional work.

Understanding compensation expectations is important when planning your career. Nurses with a Doctor of Nursing Practice (DNP) degree can find valuable insights in the doctor of nursing practice salary data, which varies by state but generally reflects a strong earning potential for advanced practitioners.

If you’re already a Family Nurse Practitioner and looking to specialize further, consider an fnp to acnp bridge program online. These bridge programs offer flexible pathways to transition into acute care, expanding your scope of practice and enhancing career mobility.

Best Scientists Citing Isabelle Cremer

Trending Scientists

Recently Published Articles